Galapagos NV Logo

Galapagos NV

GLPG.AS

(1.2)
Stock Price

27,14 EUR

-3.6% ROA

-5.95% ROE

-15.65x PER

Market Cap.

2.381.521.158,00 EUR

0.54% DER

0% Yield

-28.14% NPM

Galapagos NV Stock Analysis

Galapagos NV Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Galapagos NV Fundamental Stock Analysis
# Analysis Rating
1 PBV

The stock's low PBV ratio (0.87x) suggests it's undervalued, making it an attractive opportunity for investors.

2 DER

The stock has a minimal amount of debt (1%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

3 Graham Number

The Graham number analysis indicates that this company's stock price is likely undervalued, raising prospects for a favorable investment opportunity.

4 ROE

The stock's ROE indicates a negative return (-6.07%) on shareholders' equity, suggesting poor financial performance.

5 ROA

The stock's ROA (-3.65%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

6 Revenue Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

7 Net Profit Growth

Throughout the last five years, this company's net profit has remained unchanged, indicating a lack of growth and making it a less favorable investment option.

8 Assets Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

9 Dividend Growth

Potential investors should be aware that the company's dividend growth has shown no upward trend in the past three years, indicating limited potential for increased returns.

10 Dividend

The company's decision to withhold dividends for three years raises questions about its ability to generate consistent returns.

11 Buffet Intrinsic Value

Based on Warren Buffett's formula, the company's stock seems overpriced (-6), indicating a potential drawback for investors as its market price exceeds its estimated intrinsic value.

Galapagos NV Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Galapagos NV Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Sell
3 RSI Hold
4 Stoch RSI Hold

Galapagos NV Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Galapagos NV Revenue
Year Revenue Growth
2004 7.777.000
2005 11.240.000 30.81%
2006 35.152.000 68.02%
2007 65.936.000 46.69%
2008 76.978.000 14.34%
2009 93.089.000 17.31%
2010 122.410.000 23.95%
2011 95.887.000 -27.66%
2012 136.268.000 29.63%
2013 137.699.000 1.04%
2014 69.368.000 -98.51%
2015 39.563.000 -75.34%
2016 129.517.000 69.45%
2017 127.087.000 -1.91%
2018 288.836.000 56%
2019 844.986.000 65.82%
2020 478.053.000 -76.76%
2021 484.846.000 1.4%
2022 505.280.000 4.04%
2023 480.108.000 -5.24%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Galapagos NV Research and Development Expenses
Year Research and Development Expenses Growth
2004 5.443.000
2005 6.700.000 18.76%
2006 15.863.000 57.76%
2007 30.633.000 48.22%
2008 38.726.000 20.9%
2009 0 0%
2010 0 0%
2011 0 0%
2012 80.258.000 100%
2013 99.380.000 19.24%
2014 111.110.000 10.56%
2015 129.714.000 14.34%
2016 139.574.000 7.06%
2017 218.502.000 36.12%
2018 322.876.000 32.33%
2019 427.320.000 24.44%
2020 523.667.000 18.4%
2021 491.707.000 -6.5%
2022 515.083.000 4.54%
2023 401.220.000 -28.38%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Galapagos NV General and Administrative Expenses
Year General and Administrative Expenses Growth
2004 4.520.000
2005 5.737.000 21.21%
2006 11.963.000 52.04%
2007 19.444.000 38.47%
2008 21.072.000 7.73%
2009 16.934.000 -24.44%
2010 21.483.000 21.17%
2011 23.120.000 7.08%
2012 18.267.000 -26.57%
2013 19.351.000 5.6%
2014 8.087.000 -139.29%
2015 19.127.000 57.72%
2016 15.160.000 -26.17%
2017 17.756.000 14.62%
2018 25.495.000 30.35%
2019 63.681.000 59.96%
2020 95.702.000 33.46%
2021 97.262.000 1.6%
2022 185.502.000 47.57%
2023 66.100.000 -180.64%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Galapagos NV EBITDA
Year EBITDA Growth
2004 -2.403.000
2005 -4.686.000 48.72%
2006 -6.090.000 23.05%
2007 -5.782.000 -5.33%
2008 -2.862.000 -102.03%
2009 9.628.000 129.73%
2010 14.222.000 32.3%
2011 -19.980.000 171.18%
2012 8.519.000 334.53%
2013 -1.833.000 564.76%
2014 -29.319.000 93.75%
2015 -55.409.000 47.09%
2016 -5.701.000 -871.92%
2017 -82.907.000 93.12%
2018 -35.072.000 -136.39%
2019 390.105.000 108.99%
2020 -165.427.000 335.82%
2021 -138.003.000 -19.87%
2022 -194.088.000 28.9%
2023 -24.964.000 -677.47%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Galapagos NV Gross Profit
Year Gross Profit Growth
2004 6.489.000
2005 6.411.000 -1.22%
2006 15.619.000 58.95%
2007 35.770.000 56.33%
2008 49.209.000 27.31%
2009 7.992.000 -515.73%
2010 6.394.000 -24.99%
2011 -29.099.000 121.97%
2012 88.090.000 133.03%
2013 96.401.000 8.62%
2014 -41.742.000 330.94%
2015 -90.151.000 53.7%
2016 -10.057.000 -796.4%
2017 -91.415.000 89%
2018 -34.040.000 -168.55%
2019 417.666.000 108.15%
2020 478.053.000 12.63%
2021 483.217.000 1.07%
2022 493.201.000 2.02%
2023 457.308.000 -7.85%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Galapagos NV Net Profit
Year Net Profit Growth
2004 -3.589.000
2005 -6.541.000 45.13%
2006 -11.335.000 42.29%
2007 -21.948.000 48.36%
2008 -14.584.000 -50.49%
2009 3.010.000 584.52%
2010 4.370.000 31.12%
2011 -33.097.000 113.2%
2012 -5.721.000 -478.52%
2013 -8.079.000 29.19%
2014 33.211.000 124.33%
2015 -118.410.000 128.05%
2016 54.012.000 319.23%
2017 -115.704.000 146.68%
2018 -29.259.000 -295.45%
2019 149.845.000 119.53%
2020 -311.001.000 148.18%
2021 -125.422.000 -147.96%
2022 -217.991.000 42.46%
2023 103.320.000 310.99%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Galapagos NV Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2004 -1
2005 -1 0%
2006 -1 0%
2007 -1 100%
2008 -1 0%
2009 0 0%
2010 0 0%
2011 -1 100%
2012 0 0%
2013 0 0%
2014 1 100%
2015 -3 133.33%
2016 1 400%
2017 -2 150%
2018 -1 0%
2019 3 100%
2020 -5 150%
2021 -2 -300%
2022 -3 66.67%
2023 2 400%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Galapagos NV Free Cashflow
Year Free Cashflow Growth
2004 -2.858.000
2005 -4.998.000 42.82%
2006 -13.576.000 63.19%
2007 -5.674.000 -139.27%
2008 -13.911.000 59.21%
2009 1.117.000 1345.39%
2010 -22.826.000 104.89%
2011 -17.824.000 -28.06%
2012 57.268.000 131.12%
2013 -7.351.000 879.05%
2014 -78.359.000 90.62%
2015 -121.255.000 35.38%
2016 234.613.000 151.68%
2017 -154.467.000 251.89%
2018 -156.183.000 1.1%
2019 3.162.932.000 104.94%
2020 -518.651.000 709.84%
2021 -561.706.000 7.67%
2022 -537.491.000 -4.51%
2023 -122.020.000 -340.49%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Galapagos NV Operating Cashflow
Year Operating Cashflow Growth
2004 -2.710.000
2005 -3.887.000 30.28%
2006 -9.310.000 58.25%
2007 371.000 2609.43%
2008 -8.209.000 104.52%
2009 6.303.000 230.24%
2010 -18.573.000 133.94%
2011 -11.991.000 -54.89%
2012 64.104.000 118.71%
2013 522.000 -12180.46%
2014 -75.555.000 100.69%
2015 -114.590.000 34.06%
2016 239.403.000 147.86%
2017 -147.030.000 262.83%
2018 -142.466.000 -3.2%
2019 3.208.617.000 104.44%
2020 -427.336.000 850.84%
2021 -503.827.000 15.18%
2022 -500.544.000 -0.66%
2023 -118.818.000 -321.27%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Galapagos NV Capital Expenditure
Year Capital Expenditure Growth
2004 148.000
2005 1.111.000 86.68%
2006 4.266.000 73.96%
2007 6.045.000 29.43%
2008 5.702.000 -6.02%
2009 5.186.000 -9.95%
2010 4.253.000 -21.94%
2011 5.833.000 27.09%
2012 6.836.000 14.67%
2013 7.873.000 13.17%
2014 2.804.000 -180.78%
2015 6.665.000 57.93%
2016 4.790.000 -39.14%
2017 7.437.000 35.59%
2018 13.717.000 45.78%
2019 45.685.000 69.97%
2020 91.315.000 49.97%
2021 57.879.000 -57.77%
2022 36.947.000 -56.65%
2023 3.202.000 -1053.87%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Galapagos NV Equity
Year Equity Growth
2004 10.367.000
2005 61.136.000 83.04%
2006 109.542.000 44.19%
2007 98.626.000 -11.07%
2008 84.324.000 -16.96%
2009 108.877.000 22.55%
2010 148.507.000 26.69%
2011 118.376.000 -25.45%
2012 118.447.000 0.06%
2013 167.136.000 29.13%
2014 206.135.000 18.92%
2015 364.999.000 43.52%
2016 758.701.000 51.89%
2017 1.011.984.000 25.03%
2018 1.214.249.000 16.66%
2019 2.875.658.000 57.77%
2020 2.670.355.000 -7.69%
2021 2.643.362.000 -1.02%
2022 2.526.026.000 -4.65%
2023 2.621.560.000 3.64%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Galapagos NV Assets
Year Assets Growth
2004 15.613.000
2005 81.563.000 80.86%
2006 167.646.000 51.35%
2007 148.724.000 -12.72%
2008 118.824.000 -25.16%
2009 143.709.000 17.32%
2010 193.961.000 25.91%
2011 161.055.000 -20.43%
2012 235.329.000 31.56%
2013 287.374.000 18.11%
2014 270.467.000 -6.25%
2015 442.514.000 38.88%
2016 1.083.338.000 59.15%
2017 1.286.274.000 15.78%
2018 1.439.496.000 10.64%
2019 6.068.609.000 76.28%
2020 5.717.731.000 -6.14%
2021 5.193.160.000 -10.1%
2022 4.734.351.000 -9.69%
2023 4.451.336.000 -6.36%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Galapagos NV Liabilities
Year Liabilities Growth
2004 5.246.000
2005 20.427.000 74.32%
2006 58.104.000 64.84%
2007 50.098.000 -15.98%
2008 34.500.000 -45.21%
2009 34.832.000 0.95%
2010 45.454.000 23.37%
2011 42.679.000 -6.5%
2012 116.882.000 63.49%
2013 120.237.000 2.79%
2014 64.332.000 -86.9%
2015 77.515.000 17.01%
2016 324.637.000 76.12%
2017 274.291.000 -18.35%
2018 225.247.000 -21.77%
2019 3.192.951.000 92.95%
2020 3.047.376.000 -4.78%
2021 2.549.798.000 -19.51%
2022 2.208.325.000 -15.46%
2023 1.829.776.000 -20.69%

Galapagos NV Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
8.21
Net Income per Share
-2.31
Price to Earning Ratio
-15.65x
Price To Sales Ratio
4.38x
POCF Ratio
-4.62
PFCF Ratio
-4.43
Price to Book Ratio
0.91
EV to Sales
4.11
EV Over EBITDA
-29.53
EV to Operating CashFlow
-4.31
EV to FreeCashFlow
-4.16
Earnings Yield
-0.06
FreeCashFlow Yield
-0.23
Market Cap
2,38 Bil.
Enterprise Value
2,24 Bil.
Graham Number
45.34
Graham NetNet
31.15

Income Statement Metrics

Net Income per Share
-2.31
Income Quality
3.39
ROE
-0.06
Return On Assets
-0.03
Return On Capital Employed
-0.04
Net Income per EBT
1.09
EBT Per Ebit
0.92
Ebit per Revenue
-0.28
Effective Tax Rate
-0.09

Margins

Sales, General, & Administrative to Revenue
0.28
Research & Developement to Revenue
0.85
Stock Based Compensation to Revenue
0.07
Gross Profit Margin
0.97
Operating Profit Margin
-0.28
Pretax Profit Margin
-0.26
Net Profit Margin
-0.28

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-7.83
Free CashFlow per Share
-8.12
Capex to Operating CashFlow
0.04
Capex to Revenue
-0.04
Capex to Depreciation
-0.88
Return on Invested Capital
-0.06
Return on Tangible Assets
-0.04
Days Sales Outstanding
49.01
Days Payables Outstanding
2500.54
Days of Inventory on Hand
1147.89
Receivables Turnover
7.45
Payables Turnover
0.15
Inventory Turnover
0.32
Capex per Share
-0.29

Balance Sheet

Cash per Share
57,52
Book Value per Share
39,56
Tangible Book Value per Share
36.51
Shareholders Equity per Share
39.56
Interest Debt per Share
0.2
Debt to Equity
0.01
Debt to Assets
0
Net Debt to EBITDA
1.92
Current Ratio
8.91
Tangible Asset Value
2,42 Bil.
Net Current Asset Value
2,13 Bil.
Invested Capital
0.01
Working Capital
3,51 Bil.
Intangibles to Total Assets
0.05
Average Receivables
0,07 Bil.
Average Payables
0,13 Bil.
Average Inventory
52236500
Debt to Market Cap
0.01

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Galapagos NV Dividends
Year Dividends Growth

Galapagos NV Profile

About Galapagos NV

Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative colitis, small bowel CD, fistulizing CD, ankylosing spondylitis, psoriatic arthritis, and uveitis. The company's pipeline products also comprise GLPG1972 that has completed Phase 2b trial for treating osteoarthritis; Toledo molecules, including GLPG3970, GLPG4399, and GLPG4876 for inflammation; and GLPG4716 and Ziritaxestat to treat idiopathic pulmonary fibrosis. In addition, its other pipeline products include GLPG2737, a cystic fibrosis transmembrane conductance regulator that is in Phase 2 clinical trials to treat patients with autosomal dominant polycystic kidney disease; and GLPG0555, a JAK1 inhibitor, which is in Phase 1b for treatment of patients with osteoarthritis. The company has collaboration agreements with Gilead Sciences, Inc.; AbbVie S.à r.l.; and Novartis Pharma AG. Galapagos NV was incorporated in 1999 and is headquartered in Mechelen, Belgium.

CEO
Dr. Paulus A. Stoffels M.D., P
Employee
1.338
Address
Generaal De Wittelaan L11 A3
Mechelen, 2800

Galapagos NV Executives & BODs

Galapagos NV Executives & BODs
# Name Age
1 Ms. Alice Dietrich
Head of Medical Affairs
70
2 Mr. Dirk De Naeyer
Head of Development Operations
70
3 Ms. Valeria Cnossen
General Counsel
70
4 Ms. Annelies Missotten
Chief Human Resources Officer
70
5 Dr. Paulus A. Stoffels M.D., Ph.D.
Chief Executive Officer, Chairman, Interim Head of R&D
70
6 Mr. Philippe Alen M.B.A., Ph.D., Pharm.D.
Senior Vice President & Head of Business Development
70
7 Ms. Sofie Van Gijsel
Head of Investor Relations
70
8 Marieke Vermeersch
Head of Corporate Communication
70
9 Ms. Ellen Van Der Aar
Head of Development
70
10 Mr. Thad Huston
Chief Financial Officer & Chief Operating Officer
70

Galapagos NV Competitors

argenx SE Logo
argenx SE

ARGX.BR

(1.0)
Pharming Group N.V. Logo
Pharming Group N.V.

PHARM.AS

(0.5)
Barco NV Logo
Barco NV

BAR.BR

(2.8)
Biocartis Group NV Logo
Biocartis Group NV

BCART.BR

(1.8)